Show simple item record

dc.contributor.authorWemer J
dc.contributor.authorVleeming W
dc.contributor.authorHoogerhout P
dc.contributor.authorPoolman JT
dc.date.accessioned2012-12-12T15:09:00Z
dc.date.available2012-12-12T15:09:00Z
dc.date.issued1994-02-28
dc.identifier319001003
dc.identifier.urihttp://hdl.handle.net/10029/257155
dc.description.abstractIn anaphylactic reactions IgE-mediated effects on the pulmonary and cardiovascular system play a pivotal role. The sequence of amino acids of the chains of the IgE-antibody is known and decapeptides can be synthesized resembling that part of the chains which binds to the mast cells resulting in the release of histamine and leucotrienes. In theory these synthetic decapeptides can be used as the first step for the vaccine development. Another approach would be the construction of peptides with binding capacity but no stimulating activity resulting in the blocking of IgE-binding sites on the target cells. In this feasibility study pilot experiments were performed on the isolated heart of the (actively TNP-ovalbumin sensitized) rat with coronary flow as parameter. Although the pilot experiments indicated an approach leading to either effective peptide antagonists or vaccines it was foreseen that reaching this goal the demand on research capacity would be substantial. In defining priorities the final conclusion was reasched to end these experiments.<br>
dc.description.sponsorshipRIVM
dc.format.extent27 p
dc.language.isonl
dc.publisherRijksinstituut voor Volksgezondheid en Milieu RIVM
dc.relation.ispartofRIVM Rapport 319001003
dc.relation.urlhttp://www.rivm.nl/bibliotheek/rapporten/319001003.html
dc.subject01nl
dc.subjectanafylaxisnl
dc.subjectigenl
dc.subjectbindingnl
dc.subjectsynthetische vaccinsnl
dc.subjectpeptidennl
dc.subjectdiermodelnl
dc.subjectanaphylaxisen
dc.subjectigeen
dc.subjectbinding sitesen
dc.subjectsynthetic vaccinesen
dc.subjectpeptidesen
dc.subjectanimal modelsen
dc.subjectconjugate vaccinesen
dc.subjectconjugaat vaccinsen
dc.titleEffecten van synthetische IgE-afgeleide peptiden en anti-IgE conjugaatvaccins in het cardiovasculaire systeem van de ratnl
dc.title.alternative[Effects of synthetic IgE-mediated peptides and anti-IgE conjugatevaccines in the cardiovascular system of the rat.]en
dc.typeReport
dc.contributor.departmentTOX
dc.contributor.departmentBVM
dc.date.updated2012-12-12T15:09:00Z
html.description.abstractIn anaphylactic reactions IgE-mediated effects on the pulmonary and cardiovascular system play a pivotal role. The sequence of amino acids of the chains of the IgE-antibody is known and decapeptides can be synthesized resembling that part of the chains which binds to the mast cells resulting in the release of histamine and leucotrienes. In theory these synthetic decapeptides can be used as the first step for the vaccine development. Another approach would be the construction of peptides with binding capacity but no stimulating activity resulting in the blocking of IgE-binding sites on the target cells. In this feasibility study pilot experiments were performed on the isolated heart of the (actively TNP-ovalbumin sensitized) rat with coronary flow as parameter. Although the pilot experiments indicated an approach leading to either effective peptide antagonists or vaccines it was foreseen that reaching this goal the demand on research capacity would be substantial. In defining priorities the final conclusion was reasched to end these experiments.&lt;br&gt;


This item appears in the following Collection(s)

Show simple item record